Evidence map›Paper›PMID 41669507›Full record

ArticleCirculation reports2026

Prognostic Stratification Based on Left Ventricular Diastolic Dysfunction and Coronary Microvascular Dysfunction in Patients Without Functional Coronary Artery Stenosis.

Aki Ito, Tadashi Murai, Hiroyuki Hikita, Masao Yamaguchi, Takumi Matsumoto, Yuudai Yamaguchi, Ippei Saito, Hiroyuki Masumoto, Hiroshi Yoshikawa, Yoshinori Kanno and 6 more

Abstract read
In one paragraph

Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aki ItoCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Tadashi MuraiCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Hiroyuki HikitaCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Masao YamaguchiDepartment of Cardiology, Yokohama Minami Kyosai Hospital Yokohama Japan.
Takumi MatsumotoCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Yuudai YamaguchiCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Ippei SaitoCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Hiroyuki MasumotoCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Hiroshi YoshikawaDepartment of Cardiology, Hiratsuka Kyosai Hospital Kanagawa Japan.
Yoshinori KannoDepartment of Cardiovascular Medicine, Institute of Science Tokyo Hospital Tokyo Japan.
Keiichi HishikariCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Atsushi TakahashiCardiovascular Center, Yokosuka Kyosai Hospital Kanagawa Japan.
Hiroyuki FujiiDepartment of Cardiology, Yokohama Minami Kyosai Hospital Yokohama Japan.
Taishi YonetsuDepartment of Cardiovascular Medicine, Institute of Science Tokyo Hospital Tokyo Japan.
Tsunekazu KakutaDepartment of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital Ibaraki Japan.
Tetsuo SasanoDepartment of Cardiovascular Medicine, Institute of Science Tokyo Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The left atrial volume index (LAVi) is a sensitive surrogate marker for left ventricular diastolic dysfunction (LVDD) and is associated with poor outcomes. Although LVDD is associated with coronary microvascular dysfunction (CMD), the prognostic significance of coexisting elevated LAVi and CMD remains unclear. This study aimed to assess the significance of coexisting elevated LAVi and CMD. Methods and Results: We studied 330 patients who underwent intracoronary physiological assessment for suspected ischemia with non-obstructive coronary artery disease. Among these patients, 75 had LVDD, and 107 had coronary flow reserve (CFR) <2.5. Patients were classified into 4 groups: Group 1, normal LAVi and CFR; Group 2, elevated LAVi only; Group 3, impaired CFR only; and Group 4, abnormal LAVi and CFR. The primary endpoints were major adverse cardiovascular events (MACE), including cardiovascular death, acute coronary syndrome, and heart failure requiring hospitalization. During a median follow-up of 759 days, 16 (4.8%) patients experienced 18 events. Event-free survival was significantly lower in Group 4 than in the other groups (P<0.01). Conclusions: The coexistence of elevated LAVi and impaired CFR is associated with a significantly higher risk of MACE. The combination of LAVi and CFR may improve risk stratification in patients without epicardial coronary stenosis.

Indexed as

Coronary flow reserveCoronary microvascular dysfunctionHeart failureLeft atrial volume indexLeft ventricular diastolic dysfunction

Identifiers

PMID41669507
PMCPMC12885546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.